Recent Research | Page 78 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journalsort ascending Bone Marrow Disease
Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents Jan 2017 Am J Hematol myelodysplastic syndromes (MDS)
Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia. Jun 2013 Am J Hematol aplastic anemia
Common polymorphic deletion of glutathione S-transferase theta predisposes to acquired aplastic anemia: Independent cohort and meta-analysis of 609 patients. Jun 2013 Am J Hematol aplastic anemia
SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution Apr 2014 Am J Hematol myelodysplastic syndromes (MDS)
Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia Jun 2014 Am J Hematol aplastic anemia
Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia. Oct 2013 Am J Hematol aplastic anemia
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: A treatment versus no-treatment study Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution. Oct 2013 Am J Hematol myelodysplastic syndromes (MDS)
Evaluation of revised IPSS cytogenetic risk stratification and prognostic impact of monosomal karyotype in 783 patients with primary myelodysplastic syndromes. May 2013 Am J Hematol myelodysplastic syndromes (MDS)